From November 14 to 16, 2025, the 27th China Hi-Tech Fair (CHTF) was grandly held in Shenzhen. During the event, Chipscreen Biosciences, a representative enterprise in Guangdong Province's biomedicine sector, was selected to join the science and technology exhibition group organized by the Department of Science and Technology of Guangdong Province. Alongside 75 other enterprises and institutions, the company showcased its latest technological innovation achievements.

Concurrently, the innovative progress of CS231295, an original small-molecule drug independently developed by the company that has received U.S. FDA approval to initiate clinical trials, was highlighted at the parallel event, the 27th CHTF Academician Forum · Shenzhen Innovative Drug Development Forum and Major Project Signing Ceremony.

Image source: As indicated by the watermark